ABUS

#2542
Arbutus Biopharma Corporation Common Stock
4.52 USD
+3.91%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
4.51
4.58
Intervallo Annuale
2.94
5.10
Variazione giornaliera
+3.91%
Variazione Mensile
+5.12%
Variazione di 6 mesi
+0.44%
Variazione Annuale
+42.59%
Chiusura Precedente
4.35
Apertura
4.57
Bid
Ask
Minimo
4.51
High
4.58
Volume
314
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 883.56 M
  • Employee 19
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-28.29
Rapporto prezzo/fatturato
65.44

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Notizie